Patient Monitoring Devices Market By Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031

icon1
USD 76.11 BN
MARKET SIZE, 2031
icon2
CAGR 6.4%
(2026-2031)
icon3
300
REPORT PAGES
icon4
250
MARKET TABLES

OVERVIEW

patient-healthcare-monitoring-systems-devices-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The rising prevalence of chronic diseases worldwide is a major factor driving demand for patient monitoring devices. Patients with conditions such as cardiovascular diseases, diabetes, respiratory disorders, and hypertension require continuous monitoring for timely diagnosis and effective disease management. The growing older population, rising hospital admissions, and increasing need for remote patient monitoring are placing greater pressure on healthcare systems. As a result, hospitals and healthcare providers are investing in advanced patient monitoring technologies to improve patient outcomes and reduce the burden on healthcare facilities. Furthermore, the increasing adoption of connected healthcare solutions, wearable technologies, and AI-enabled monitoring systems is accelerating market growth. This trend is expected to sustain long-term demand for patient monitoring devices, particularly in regions with expanding healthcare infrastructure and increasing focus on preventive care.

KEY TAKEAWAYS

  • BY Country
    India is expected to register the highest CAGR of 9.1% during the forecast period.
  • BY PRODUCT
    By product, the blood glucose monitoring devices segment is expected to register a CAGR of 6.4% during the forecast period.
  • BY END USER
    By end user, hospitals & clinics are projected to grow at a CAGR of 6.4% till 2031.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    Medtronic Plc (Ireland), Abbott Laboratories (US), GE HealthCare (US), Philips Healthcare (Netherlands), and Nihon Kohden Corporation (Japan) were identified as Star Players in the patient monitoring devices market due to their strong focus on innovation, extensive product portfolios, broad industry presence, and robust operational and financial capabilities.
  • COMPETITIVE LANDSCAPE - STARTUPS/SMES
    Dexcom, Inc. (US), Compumedics Limited (Australia), and Nonin Medical, Inc. (US) are some startups and SMEs due to their strong product portfolio and business strategies.

Rapid improvements in healthcare infrastructure across emerging economies are significantly contributing to the growth of the patient monitoring devices market. Governments and private healthcare providers across regions such as Asia-Pacific, Latin America, and parts of the Middle East and Africa are increasing investments in hospitals, specialty care centers, and critical care facilities. These investments are aimed at improving healthcare delivery and expanding access to advanced medical technologies, thereby increasing the adoption of patient monitoring systems. Additionally, rising healthcare expenditure and expanding health insurance coverage are enabling broader access to monitoring and diagnostic solutions. Public health initiatives and digital healthcare programs are also accelerating the deployment of connected monitoring technologies. As a result, underserved regions are witnessing increasing demand for cost-effective and advanced patient monitoring devices, creating opportunities for manufacturers to introduce innovative and accessible solutions tailored to local healthcare needs.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The patient monitoring devices market is evolving from traditional standalone monitoring systems toward connected, intelligent, and patient-centric healthcare platforms that support hospitals, home care, and remote care settings. Rising demand for continuous monitoring, wearable technologies, and non-invasive devices is reshaping customer expectations across healthcare facilities. Digital ecosystems integrating remote patient monitoring, AI-enabled analytics, telehealth, and smart device connectivity are accelerating adoption. As healthcare providers increasingly prioritize real-time data, early diagnosis, and personalized care, manufacturers are focusing on compact designs, wearable solutions, software-driven monitoring, strategic partnerships, and integrated care models. The growing shift toward home-based care and connected healthcare infrastructure is further driving innovation across the patient monitoring devices market.

patient-healthcare-monitoring-systems-devices-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising prevalence of chronic diseases
  • Growing aging population
RESTRAINTS
Impact
Level
  • Availability of alternative diagnostic and monitoring approaches
  • Stringent regulatory requirements for device approval
OPPORTUNITIES
Impact
Level
  • Growing demand for remote and home-based patient monitoring
  • Expansion of wearable and AI-enabled monitoring technologies
CHALLENGES
Impact
Level
  • Rising adoption of refurbished monitoring devices
  • Limited healthcare infrastructure in developing regions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, respiratory diseases, and hypertension is a major driver for the patient monitoring devices market. Patients suffering from these conditions require continuous monitoring for early diagnosis, disease management, and timely intervention. The growing burden of chronic illnesses, combined with an aging population and increasing healthcare awareness, has significantly increased demand for monitoring technologies. Additionally, healthcare providers are increasingly adopting advanced monitoring systems to improve patient outcomes and reduce hospital readmissions. The expansion of remote care and home-based healthcare is further accelerating demand for continuous monitoring solutions.

Restraint: Availability of alternative diagnostic and monitoring approaches

One of the key restraints in the patient monitoring devices market is the availability of alternative diagnostic methods and treatment approaches. In some cases, physicians rely on periodic laboratory testing, imaging procedures, or traditional clinical assessments rather than continuous monitoring devices. Cost concerns, workflow limitations, and varying clinical preferences can also reduce dependence on advanced monitoring systems. As a result, patient monitoring devices may not always be the primary solution across all healthcare settings.

Opportunity: Growing demand for remote and home-based patient monitoring

The increasing adoption of telehealth and home healthcare services presents a significant opportunity for the patient monitoring devices market. As healthcare systems prioritize preventive care and reduce hospital burden, demand for connected monitoring technologies is rising. Wearable devices, wireless monitoring systems, and AI-enabled platforms allow healthcare providers to monitor patients remotely while improving convenience and reducing healthcare costs. Advances in digital health infrastructure and smartphone integration are further supporting market expansion.

Challenge: Rising adoption of refurbished monitoring devices

The growing adoption of refurbished patient monitoring devices presents a challenge for manufacturers of new systems. Hospitals and healthcare facilities, particularly in cost-sensitive markets, often prefer refurbished devices due to their lower cost. This reduces demand for newly manufactured equipment and impacts revenue growth. Concerns regarding quality, maintenance, and limited standardization of refurbished devices also create challenges for the market, while increasing pricing pressure on original device manufacturers.

PATIENT MONITORING DEVICES MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Develops advanced patient monitoring solutions including continuous monitoring systems for cardiovascular, respiratory, and critical care applications across hospitals and homecare settings. The company’s solutions provide real-time patient data, improve clinical decision-making, and support better patient outcomes across healthcare settings.
Offers patient monitoring solutions including continuous glucose monitoring (CGM), cardiac monitoring, and connected care technologies for hospitals and remote care settings. Its advanced sensor technologies enhance disease management, enable remote monitoring, and improve overall patient care efficiency.
Provides integrated patient monitoring systems for intensive care units, emergency departments, and perioperative settings with advanced analytics and connectivity features. These systems improve workflow efficiency, enable centralized monitoring, and support seamless integration across hospital networks.
Delivers connected patient monitoring platforms with wearable technologies and remote monitoring capabilities across acute and home healthcare environments. The solutions enhance patient safety, provide AI-driven insights, and support effective remote care management.
Manufactures patient monitoring and diagnostic systems focused on critical care, emergency care, and hospital monitoring applications. Its technologies deliver reliable performance, improve monitoring accuracy, and support efficient patient management in clinical environments.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem map of the overall patient monitoring devices market comprises the key elements present across the healthcare value chain and defines these elements through the involvement of multiple stakeholders. It includes patient monitoring systems such as bedside monitors, wearable monitoring devices, cardiac monitoring systems, blood glucose monitoring devices, respiratory monitoring equipment, and remote patient monitoring platforms, along with related sensors, software platforms, connectivity solutions, and associated services. Manufacturers in this market are involved in research, product development, regulatory approvals, and commercialization of monitoring technologies. These companies may operate through in-house manufacturing facilities or collaborate with contract development and manufacturing organizations (CDMOs) for production and assembly. Distributors within this ecosystem include medical device suppliers, third-party distributors, healthcare technology providers, and e-commerce channels that support product availability across regions. Research and development activities involve in-house R&D centers, academic institutions, healthcare organizations, and technology partners contributing to innovations such as AI-enabled monitoring, wearable sensors, wireless connectivity, and real-time data analytics. Regulatory agencies and certification bodies play a critical role in ensuring compliance with safety, quality, and performance standards before products reach the market. The end-user segment includes hospitals, clinics, ambulatory care centers, home healthcare settings, and long-term care facilities where patient monitoring devices are widely deployed. These end users represent major demand drivers within the ecosystem. Additionally, investors, healthcare organizations, government agencies, and reimbursement bodies act as key influencers, shaping product innovation, adoption trends, and expansion strategies in the patient monitoring devices market.

patient-healthcare-monitoring-systems-devices-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

patient-healthcare-monitoring-systems-devices-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Patient Monitoring Devices Market, by Product

The blood glucose monitoring devices segment includes self-monitoring blood glucose (SMBG) devices, continuous glucose monitoring (CGM) devices, and wearable glucose monitoring devices, and accounts for a significant market share due to the rising prevalence of diabetes and growing demand for continuous disease management. Other major product categories include ECG devices, implantable loop recorders (ILRs), pulse oximeters, spirometers, EEG machines, blood pressure monitors, fetal & neonatal monitors, and wearable temperature monitoring devices. Increasing adoption of connected healthcare, remote monitoring, and wearable technologies is further driving market growth.

Patient Monitoring Devices Market, by End User

Hospitals & clinics account for the largest market share. The segment's dominance is attributed to increasing patient admissions, rising prevalence of chronic diseases, and growing demand for continuous monitoring in critical care and emergency settings. Hospitals and clinics extensively utilize multiparameter monitors, ECG systems, pulse oximeters, blood pressure monitors, fetal & neonatal monitors, and hemodynamic monitoring systems for real-time patient assessment and disease management. Additionally, increasing investments in connected healthcare technologies and integrated monitoring platforms are further driving adoption to improve patient safety, workflow efficiency, and clinical outcomes.

REGION

Rapid Healthcare Expansion in APAC Driving Patient Monitoring Market Growth

Healthcare infrastructure across Asia Pacific is rapidly evolving, driven by economic growth, increasing healthcare expenditure, and stronger government focus on improving healthcare access. Countries such as India, China, and Indonesia are investing significantly in building hospitals, upgrading healthcare facilities, and expanding critical care capabilities. The establishment of modern hospitals and specialty care centers in both urban and rural regions is improving access to advanced healthcare technologies, including patient monitoring systems. Additionally, private healthcare providers are increasingly investing in digital healthcare infrastructure and connected care solutions. The expansion of tier-2 and tier-3 cities as healthcare hubs is further increasing demand for monitoring technologies in previously underserved areas. With improved healthcare infrastructure comes increased procurement of patient monitoring devices such as multiparameter monitors, ECG systems, pulse oximeters, and wearable monitoring solutions, making infrastructure expansion a key driver of market growth in the region.

patient-healthcare-monitoring-systems-devices-market Region

PATIENT MONITORING DEVICES MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX

In the patient monitoring devices market, Medtronic Plc (Star Player) leads with a broad portfolio and strong global presence, while Dexcom, Inc. (Emerging Leader) is strengthening its position through innovation in CGM and connected monitoring technologies. Medtronic has a broad and well-established portfolio spanning cardiac monitoring, hemodynamic monitoring, wearable technologies, respiratory monitoring, and remote patient monitoring solutions. Dexcom, Inc. (Emerging Leader) is recognized as an Emerging Leader for its strong specialization in continuous glucose monitoring (CGM) technologies and rapid advancements in connected patient care solutions. The company has introduced innovative sensor-based monitoring platforms that support real-time data tracking and remote patient management. Dexcom’s growing emphasis on digital health integration, smartphone connectivity, and user-friendly monitoring systems has strengthened its market presence.

patient-healthcare-monitoring-systems-devices-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 52.60 BN
Market Forecast in 2026 (Value) USD 55.60 BN
Market Forecast in 2031 (Value) USD 76.11 BN
Growth Rate CAGR of 6.4% from 2026-2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD BN), Volume (Thousand/Million Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Product:
    • Multiparameter
    • Glucose CGM
    • Wearables
    • EEG
    • EMG
    • ICP
    • ECG
    • ILR
    • MCT
    • Pulse Oximeter
    • Fetal
    • Neonatal
    • BP
    • Hemodynamic
    • Spirometer
    • Capnograph
  • By End User:
    • Hospital
    • ICU
    • ASC
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa, GCC Countries

WHAT IS IN IT FOR YOU: PATIENT MONITORING DEVICES MARKET: GROWTH, SIZE, SHARE, AND TRENDS REPORT CONTENT GUIDE

patient-healthcare-monitoring-systems-devices-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Comparative analysis of patient monitoring device technologies by product type, including multiparameter monitors, blood glucose monitoring devices, wearable monitoring systems, ECG, EEG, pulse oximeters, fetal & neonatal monitors, hemodynamic monitoring systems, spirometers, and capnography devices, along with evaluation across hospital, ICU, ambulatory, and homecare applications. Assessment of device performance through parameters such as monitoring accuracy, real-time connectivity, portability, ease of use, AI integration, remote monitoring capability, maintenance requirements, and cost efficiency to support optimal product selection and healthcare outcomes.
Company Information Detailed profiles of leading global and regional patient monitoring device manufacturers including Medtronic Plc., Abbott Laboratories, GE HealthCare, Philips Healthcare, Nihon Kohden, Mindray, and Masimo, covering product portfolios, monitoring technologies, strategic initiatives, geographic presence, partnerships, and recent product developments. Competitive benchmarking across key players highlighting positioning by technological innovation, connected healthcare capabilities, product differentiation, pricing strategies, distribution networks, and focus areas such as critical care, remote patient monitoring, and home healthcare.
Geographic Analysis In-depth regional assessment of the global patient monitoring devices market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with analysis of healthcare infrastructure, digital health adoption, and critical care capacity trends. Country-level market sizing, CAGR forecasts, chronic disease prevalence analysis, healthcare expenditure trends, aging population assessment, and demand outlook across major markets such as the US, Germany, UK, China, India, and Japan.

RECENT DEVELOPMENTS

  • February 2025 : Medtronic Plc announced advancements in its connected patient monitoring ecosystem, strengthening remote monitoring and AI-enabled patient management capabilities for hospital and homecare settings.
  • January 2025 : Abbott Laboratories expanded its continuous glucose monitoring portfolio with enhancements focused on improved sensor accuracy, connectivity, and real-time patient data access.
  • March 2025 : GE HealthCare introduced next-generation patient monitoring solutions with enhanced predictive analytics and integrated clinical decision support capabilities for critical care environments.
  • December 2024 : Philips Healthcare expanded its remote patient monitoring platform with advanced digital health integration and cloud-based patient management features.
  • April 2025 : Dexcom, Inc. strengthened its continuous glucose monitoring technology portfolio through innovations focused on improved wearable monitoring performance and broader connected healthcare integration.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
34
RESEARCH METHODOLOGY
39
EXECUTIVE SUMMARY
56
PREMIUM INSIGHTS
59
MARKET OVERVIEW
63
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Emergence of predictive analytics in vital sign monitors
    - Growing preference for wearable patient monitoring devices, biosensors, and smart implants
    - Availability of wireless monitoring devices
    - Expansion of telehealth services and remote monitoring capabilities
    - Growing incidence of chronic diseases
    RESTRAINTS
    - Risks associated with invasive monitoring devices
    - High cost of patient monitoring products and inadequate reimbursement
    OPPORTUNITIES
    - Integration with electronic health records (EHRs)
    - Expansion of remote patient monitoring in home healthcare settings
    CHALLENGES
    - Lack of personnel and limited awareness & education for patient monitoring devices
    - Increased pricing pressure on market players
  • 5.3 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 REGULATORY ANALYSIS
  • 5.5 KEY REGULATORY GUIDELINES
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - India
    - China
  • 5.6 REIMBURSEMENT SCENARIO
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Smart wearable monitoring devices
    - Vital sign monitors
    COMPLEMENTARY TECHNOLOGIES
    - Remote patient monitors
    - AI & IoT
    - Telehealth
    ADJACENT TECHNOLOGIES
    - IVD
    - Medical imaging
  • 5.10 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT
    PROCUREMENT AND PRODUCT DEVELOPMENT
    MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
  • 5.11 SUPPLY CHAIN ANALYSIS
    PROMINENT COMPANIES
    SMALL & MEDIUM-SIZED COMPANIES
    END USERS
  • 5.12 PRICING ANALYSIS
  • 5.13 PATENT ANALYSIS
  • 5.14 TRADE ANALYSIS
  • 5.15 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.18 PATIENT MONITORING MARKET: RECESSION IMPACT
  • 5.19 UNMET NEEDS & KEY PAIN POINTS
PATIENT MONITORING MARKET, BY PRODUCT
100
  • 6.1 INTRODUCTION
  • 6.2 BLOOD GLUCOSE MONITORING DEVICES
    SELF-MONITORING BLOOD GLUCOSE DEVICES
    - Rising adoption of integrated glucose monitoring devices to drive growth
    CONTINUOUS GLUCOSE MONITORING DEVICES
    - Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth
    WEARABLE GLUCOSE MONITORING DEVICES
    - Growing patient inclination towards wearable monitors to boost market
  • 6.3 CARDIAC MONITORING DEVICES
    ECG DEVICES
    - Low cost and wide applications of ECG devices to drive market growth
    IMPLANTABLE LOOP RECORDERS (ILRS)
    - High cost and limited applications to limit growth
    EVENT MONITORS
    - Emergence of portable and wireless event monitors to drive market growth
    MCT MONITORS
    - Availability of alternate technologies to hinder market growth
    SMART/WEARABLE ECG MONITORS
    - Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
  • 6.4 MULTIPARAMETER MONITORING DEVICES
    LOW-ACUITY MONITORS
    - Increasing adoption of low-acuity monitors in general wards to drive market growth
    MID-ACUITY MONITORS
    - Rising geriatric population to increase market growth
    HIGH-ACUITY MONITORS
    - Increasing partnerships between manufacturers and hospitals & clinics to drive device sales
  • 6.5 RESPIRATORY MONITORING DEVICES
    PULSE OXIMETERS
    - Rising adoption of pulse oximeters in home care settings to drive market growth
    SPIROMETERS
    - Technological advancements to increase adoption of spirometers
    CAPNOGRAPHS
    - Product development and growing commercial acceptance to drive market growth
    PEAK FLOW METERS
    - Low preference for peak flow meters due to high variability in measurements from different devices to hinder market growth
  • 6.6 TEMPERATURE MONITORING DEVICES
    HANDHELD TEMPERATURE MONITORING DEVICES
    - Advantages associated with handheld temperature monitoring devices to drive market growth
    TABLE-TOP TEMPERATURE MONITORING DEVICES
    - Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices
    WEARABLE CONTINUOUS MONITORING DEVICES
    - Versatile functionalities offered by wearable continuous monitoring devices to drive demand
    INVASIVE TEMPERATURE MONITORING DEVICES
    - Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices
    SMART TEMPERATURE MONITORING PATCHES
    - Long-term monitoring capabilities of smart patches to drive market growth
  • 6.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES
    HEMODYNAMIC MONITORS
    - Influx of VC funding to drive market growth
    BLOOD PRESSURE MONITORS
    - Development of wearable blood pressure monitors to drive market growth
    DISPOSABLES
    - Growing number of surgical procedures to drive growth in disposables market
  • 6.8 FETAL & NEONATAL MONITORING DEVICES
    FETAL MONITORING DEVICES
    - Rising prevalence of obstetric complications to drive market growth
    NEONATAL MONITORING DEVICES
    - Rising number of neonatal care facilities worldwide to drive market
  • 6.9 NEUROMONITORING DEVICES
    EEG MACHINES
    - Growing applications and technological advancements to favor market growth
    EMG MACHINES
    - Availability of reimbursements for EMG-assisted surgeries to boost product demand
    CEREBRAL OXIMETERS
    - Growing cases of hypoxia during surgical procedures to drive market growth
    ICP MONITORS
    - Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors
    MEG MACHINES
    - High implementation and maintenance costs of MEG devices to hinder market growth
    TCD MACHINES
    - Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth
  • 6.10 WEIGHT MONITORING DEVICES
    DIGITAL WEIGHT MONITORING DEVICES
    - Consumer preference for digital scales—a key market driver
    ANALOG WEIGHT MONITORING DEVICES
    - Rising prevalence of obesity and low cost of analog scales to support market growth
  • 6.11 OTHER PATIENT MONITORING DEVICES
PATIENT MONITORING MARKET, BY END USER
156
  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CLINICS
    ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET
  • 7.3 AMBULATORY SURGICAL CENTERS
    COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE DEMAND FOR AMBULATORY CARE
  • 7.4 HOME CARE SETTINGS
    REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
  • 7.5 OTHER END USERS
PATIENT MONITORING MARKET, BY REGION
162
  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    NORTH AMERICA: RECESSON IMPACT
    US
    - Growing number of FDA approvals for patient monitoring devices to support market growth
    CANADA
    - Growing public-private funding for research to drive market growth
  • 8.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising healthcare expenditure and manufacturer expansion to boost market growth
    UK
    - Increasing public & private investments to contribute to market growth
    FRANCE
    - Statutory health insurance system to support market growth
    ITALY
    - Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
    SPAIN
    - Growing number of surgical procedures to drive market growth in Spain
    REST OF EUROPE
  • 8.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMAPCT
    JAPAN
    - Large geriatric population and favorable reimbursement scenario to support market growth
    CHINA
    - Growing focus of local and international market players to favor market growth
    INDIA
    - Increasing government-implemented healthcare initiatives to support market growth
    AUSTRALIA
    - R&D Tax Incentive Program to support market growth
    SOUTH KOREA
    - Supportive government initiatives to drive market growth
    REST OF ASIA PACIFIC
  • 8.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMAPCT
    BRAZIL
    - Brazil to dominate LATAM market
    MEXICO
    - Favorable investment scenario for medical device manufacturers to drive market growth
    REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST & AFRICA
    AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES IN REGION
    MIDDLE EAST & AFRICA: RECESSION IMAPCT
COMPETITIVE LANDSCAPE
297
  • 9.1 OVERVIEW
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PATIENT MONITORING PLAYERS
  • 9.3 REVENUE ANALYSIS
  • 9.4 MARKET SHARE ANALYSIS
    GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
    GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • 9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS
  • 9.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 9.7 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
  • 9.8 COMPANY VALUATION & FINANCIAL METRICS
  • 9.9 PRODUCT/BRAND COMPARISON
COMPANY PROFILES
319
  • 10.1 KEY PLAYERS
    MEDTRONIC PLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT LABORATORIES
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DEXCOM, INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    PHILIPS HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    NIHON KOHDEN CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    MINDRAY MEDICAL INTERNATIONAL LTD.
    - Business overview
    - Products offered
    - Recent developments
    EDWARDS LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    GETINGE AB
    - Business overview
    - Products offered
    - Recent developments
    BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.)
    - Business overview
    - Products offered
    - Recent developments
    DRÄGERWERK AG & CO. KGAA
    - Business overview
    - Products offered
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    MASIMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    OMRON CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    ARCHIMED SAS (NATUS MEDICAL)
    - Business overview
    - Products offered
    - Recent developments
    COMPUMEDICS LIMITED
    - Business overview
    - Products offered
    - Recent developments
    NONIN MEDICAL, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 10.2 OTHER PLAYERS
    BIOTRONIK
    SCHILLER AG
    SENSEONICS
    CARDIOMO
    VITLS
    NETEERA
    QARDIO
    VIVIFY HEALTH
    IRHYTHM TECHNOLOGIES, INC.
    OSYPKA MEDICAL
    CARDINAL HEALTH
    MERIT MEDICAL SYSTEMS
APPENDIX
405
  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 11.3 CUSTOMIZATION OPTIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 LIMITATIONS AND ASSOCIATED RISKS
  • TABLE 2 PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT
  • TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
  • TABLE 14 AVERAGE SELLING PRICE OF PATIENT MONITORING MARKET, BY REGION, 2023
  • TABLE 15 IMPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
  • TABLE 16 EXPORT DATA FOR PATIENT MONITORING DEVICES (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
  • TABLE 17 PATIENT MONITORING MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2024–2025
  • TABLE 18 KEY REQUIREMENTS OF DEPARTMENTS/STAKEHOLDERS WHILE BUYING PATIENT MONITORING DEVICES
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
  • TABLE 20 PATIENT MONITORING MARKET: UNMET CUSTOMER NEEDS & KEY PAIN POINTS
  • TABLE 21 PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 22 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 23 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 24 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 25 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 26 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 27 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 28 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 31 ECG DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 32 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 33 EVENT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 MCT MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
  • TABLE 36 SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 38 MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 39 MULTIPARAMETER MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 40 LOW-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 MID-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 HIGH-ACUITY MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 44 RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 45 RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 46 PULSE OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 SPIROMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 CAPNOGRAPHS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 PEAK FLOW METERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 51 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 53 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 54 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 57 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 59 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
  • TABLE 60 SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 62 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 63 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 64 HEMODYNAMIC MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
  • TABLE 66 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 69 FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 71 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 72 FETAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 NEONATAL MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 NEUROMONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NEUROMONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 77 EEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 EMG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 79 CEREBRAL OXIMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 ICP MONITORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 81 MEG MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 TCD MACHINES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 83 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 85 WEIGHT MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 86 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 88 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
  • TABLE 89 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
  • TABLE 90 OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 91 OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 92 PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 93 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 PATIENT MONITORING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 95 PATIENT MONITORING MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 96 PATIENT MONITORING MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 97 PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 98 PATIENT MONITORING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 111 VC FUNDING IN PATIENT MONITORING MARKET IN US
  • TABLE 112 US: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 113 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 RESEARCH GRANTS IN PATIENT MONITORING MARKET IN CANADA
  • TABLE 123 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING MARKET
  • TABLE 124 CANADA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 125 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING MARKET
  • TABLE 135 EUROPE: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 137 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 147 GERMANY: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 148 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 UK: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 158 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 FRANCE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 168 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 ITALY: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 178 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 SPAIN: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 188 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN PATIENT MONITORING MARKET IN ROE
  • TABLE 198 REST OF EUROPE: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 199 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 210 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 220 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN JAPAN
  • TABLE 221 JAPAN: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 222 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN CHINA
  • TABLE 232 CHINA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 233 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 237 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 INDIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 243 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 AUSTRALIA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 253 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 SOUTH KOREA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 263 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 RECENT DEVELOPMENTS IN PATIENT MONITORING MARKET IN ROAPAC
  • TABLE 273 REST OF ASIA PACIFIC: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 274 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 LATIN AMERICA: PATIENT MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 285 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 295 BRAZIL: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 296 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 305 MEXICO: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 306 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 311 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 312 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 313 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 314 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 315 REST OF LATIN AMERICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 316 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 321 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 322 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 323 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 325 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 326 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 331 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 334 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 MIDDLE EAST & AFRICA: PATIENT MONITORING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 336 PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • TABLE 337 PRODUCT FOOTPRINT (20 COMPANIES)
  • TABLE 338 END USER FOOTPRINT (20 COMPANIES)
  • TABLE 339 REGIONAL FOOTPRINT (20 COMPANIES)
  • TABLE 340 PATIENT MONITORING MARKET: DETAILED LIST OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 341 PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 342 PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2023
  • TABLE 343 PATIENT MONITORING MARKET: DEALS, JANUARY 2021–FEBRUARY 2024
  • TABLE 344 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 345 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 346 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS
  • TABLE 347 MEDTRONIC PLC: DEALS
  • TABLE 348 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 349 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 350 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
  • TABLE 351 ABBOTT LABORATORIES: DEALS
  • TABLE 352 DEXCOM, INC.: COMPANY OVERVIEW
  • TABLE 353 DEXCOM, INC.: PRODUCTS OFFERED
  • TABLE 354 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 355 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 356 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 357 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
  • TABLE 358 GE HEALTHCARE: DEALS
  • TABLE 359 PHILIPS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 360 PHILIPS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 361 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
  • TABLE 362 PHILIPS HEALTHCARE: DEALS
  • TABLE 363 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 364 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
  • TABLE 365 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 366 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW
  • TABLE 367 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED
  • TABLE 368 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS
  • TABLE 369 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS
  • TABLE 370 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 371 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 372 GETINGE AB: COMPANY OVERVIEW
  • TABLE 373 GETINGE AB: PRODUCTS OFFERED
  • TABLE 374 GETINGE AB: PRODUCT LAUNCHES & APPROVALS
  • TABLE 375 GETINGE AB: DEALS
  • TABLE 376 BAXTER INTERNATIONAL: COMPANY OVERVIEW
  • TABLE 377 BAXTER INTERNATIONAL: PRODUCTS OFFERED
  • TABLE 378 BAXTER INTERNATIONAL: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
  • TABLE 379 BAXTER INTERNATIONAL: DEALS
  • TABLE 380 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 381 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED
  • TABLE 382 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 383 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 384 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 385 BOSTON SCIENTIFIC CORPORATION: DEALS
  • TABLE 386 MASIMO CORPORATION: COMPANY OVERVIEW
  • TABLE 387 MASIMO CORPORATION: PRODUCTS OFFERED
  • TABLE 388 MASIMO CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 389 MASIMO CORPORATION: DEALS
  • TABLE 390 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 391 OMRON CORPORATION: PRODUCTS OFFERED
  • TABLE 392 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS
  • TABLE 393 OMRON CORPORATION: DEALS
  • TABLE 394 ARCHIMED SAS (NATUS MEDICAL): BUSINESS OVERVIEW
  • TABLE 395 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED
  • TABLE 396 ARCHIMED SAS (NATUS MEDICAL): DEALS
  • TABLE 397 COMPUMEDICS LIMITED: BUSINESS OVERVIEW
  • TABLE 398 COMPUMEDICS LIMITED: PRODUCTS OFFERED
  • TABLE 399 COMPUMEDICS LIMITED: PRODUCT LAUNCHES & APPROVALS
  • TABLE 400 COMPUMEDICS LIMITED: DEALS
  • TABLE 401 NONIN MEDICAL, INC.: BUSINESS OVERVIEW
  • TABLE 402 NONIN MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 403 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS
LIST OF FIGURES
 
  • FIGURE 1 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5 PATIENT MONITORING MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 6 PATIENT MONITORING MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 7 PATIENT MONITORING MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 GROWTH PROJECTIONS WERE BASED ON REVENUE IMPACT OF KEY MACROINDICATORS
  • FIGURE 10 PATIENT MONITORING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF PATIENT MONITORING MARKET
  • FIGURE 13 GROWING ADOPTION OF WIRELESS MONITORING DEVICES TO DRIVE MARKET GROWTH
  • FIGURE 14 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 15 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 16 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 17 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 NUMBER OF DEALS & FUNDINGS IN PATIENT MONITORING MARKET, 2018-2022 (USD MILLION)
  • FIGURE 19 NUMBER OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018–2022
  • FIGURE 20 VALUE OF INVESTOR DEALS IN PATIENT MONITORING MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 21 PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 23 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY PRODUCT (FY 2021–2023)
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF PATIENT MONITORING DEVICES, BY REGION, 2021–2023 (USD)
  • FIGURE 25 PATENT DETAILS FOR PATIENT MONITORING DEVICES (JANUARY 2013–DECEMBER 2023)
  • FIGURE 26 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
  • FIGURE 27 BUYING CRITERIA
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
  • FIGURE 29 NORTH AMERICA: PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 30 ASIA PACIFIC: PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 31 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)
  • FIGURE 32 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
  • FIGURE 33 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
  • FIGURE 34 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
  • FIGURE 35 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
  • FIGURE 36 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
  • FIGURE 37 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 38 COMPANY FOOTPRINT (20 COMPANIES)
  • FIGURE 39 PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL (2023)
  • FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 45 DEXCOM, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 47 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 48 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT (2022)
  • FIGURE 50 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 51 GETINGE AB.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2023)
  • FIGURE 53 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 55 MASIMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 56 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 57 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023)

 

Methodology

The study involved major activities in estimating the current market size for the patient monitoring devices market. Exhaustive secondary research was done to collect information on the patient monitoring devices market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the patient monitoring devices market.

Secondary Research

This research study involved the extensive use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and Companies House documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the patient monitoring devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Market-Related Personnel from various companies and organizations operating in the patient monitoring devices market. Primary sources from the demand side included Law Enforcement Agencies, Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Team of Hospitals, Clinic Personnel, and Laboratory Technicians.

Patient Monitoring Devices Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primary roles include sales, marketing, and product management.

Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the patient monitoring devices market. These methods were also used extensively to estimate the sizes of various market subsegments. The research methodology used to estimate the market size includes the following:

Patient Monitoring Devices Market : Top-Down and Bottom-Up Approach

Patient Monitoring Devices Market Top Down and Bottom Up Approach

Data Triangulation

The entire market was split into two segments when the market size was determined. Data triangulation and market breakdowns were used as needed to complete the market engineering process and derive precise statistics for all segments.

pproach for deriving the market size and estimating market growth.

sing secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of patient monitoring devices. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Patient monitoring devices continuously measure and track physiological parameters to manage various medical conditions, including cardiovascular diseases, diabetes, respiratory disorders, neurological conditions, and critical care situations, providing real-time insights into patient health.

Key Stakeholders

  • Patient monitoring device manufacturing companies
  • Patient monitoring device components and accessories manufacturing companies
  • Patient monitoring device suppliers and distributors
  • Hospitals and clinics
  • Ambulatory surgical centers (ASCs)
  • Home healthcare service providers
  • Physicians, intensivists, cardiologists, and healthcare professionals
  • Research laboratories and academic institutions
  • Contract manufacturers and technology solution providers
  • Digital health and remote patient monitoring platform providers
  • Regulatory authorities and healthcare organizations
  • Distributors, suppliers, and commercial service providers

Report Objectives

  • To describe, analyze, and forecast the patient monitoring devices market by product, end user, and region
  • To describe and forecast the patient monitoring devices market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa, and GCC Countries
  • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the patient monitoring devices market
  • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the patient monitoring devices market
  • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the patient monitoring devices market

Customization Options

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific patient monitoring devices market into Vietnam, New Zealand, and others.
  • Further breakdown of the Rest of Latin America patient monitoring devices market by country, including Colombia, Chile, Ecuador, and others.
  • Further breakdown of the Rest of Europe patient monitoring devices market into Belgium, Russia, the Netherlands, Switzerland, and others.

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Patient Monitoring Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Patient Monitoring Devices Market

DMCA.com Protection Status